Dianthus Therapeutics (DNTH) EPS (Basic) Growth (3y) (2020 - 2025)
Dianthus Therapeutics (DNTH) EPS (Basic) Growth (3y) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 53.55% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 37.73% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.29% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -2.89% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 86.43% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Dianthus Therapeutics | 3.37 Bn | 2.97 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 4.54% |
| Jun 30, 2025 | 44.19% |
| Mar 31, 2025 | 46.74% |
| Dec 31, 2024 | 55.27% |
| Sep 30, 2024 | 30.57% |
| Jun 30, 2024 | 36.35% |
| Mar 31, 2024 | 56.43% |
| Dec 31, 2023 | 55.77% |
| Sep 30, 2023 | 10.29% |
| Jun 30, 2023 | 34.23% |
| Mar 31, 2023 | 44.72% |
| Dec 31, 2022 | 35.39% |
| Sep 30, 2022 | 16.57% |
| Jun 30, 2022 | -1.66% |
| Mar 31, 2022 | -6.98% |
| Dec 31, 2021 | 17.44% |
| Sep 30, 2021 | 5.75% |
| Jun 30, 2021 | 47.22% |
| Mar 31, 2021 | 51.06% |
| Dec 31, 2020 | 21.28% |